CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Wave Life Sciences

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.

GlaxoSmithKline USA

GlaxoSmithKline USA is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chancellor Health Trust

Chancellor Health Trust is a Palm Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hemet Ekg Interpretation Med

Hemet Ekg Interpretation Med is a Hemet, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Crystal Lake Healthcare

Crystal Lake Healthcare is a Bayville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.